Literature DB >> 10425175

Inhibition of mutant p53 phosphorylation at serine 15 or serine 315 partially restores the function of wild-type p53.

E Sugikawa1, N Yazaki, S Tsunoda, N Nakanishi, M Ohashi.   

Abstract

The tumor suppressor protein p53 is a phosphoprotein and has growth and transformation suppression functions. Phosphorylation of wild-type p53 is known to modulate its function. To investigate the role of phosphorylation in modulating the functions of mutant p53, we constructed a series of phosphorylation site mutants based on mutant p53 Ala143 (p53-143) and p53 His175 (p53-175). When transfected into p53-negative Saos-2 cells, parental mutant p53-143 and p53-175 abolished both growth suppression and induction of apoptosis. However, DNA-activated protein kinase (DNA-PK) or cyclin-dependent kinase (cdks) phosphorylation site double mutants partially restored the growth suppression and induction of apoptosis and recovered the p53-specific DNA binding activity. We also observed a difference in sensitivity to calpain from parental mutants p53-175 and p53-175/15 or p53-175/315. These results suggest that the lack of phosphorylation at either the DNA-PK or cdks site in p53 mutants partially restores the wild-type functions by altering their conformation. Copyright 1999 Academic Press.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10425175     DOI: 10.1006/bbrc.1999.1019

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  5 in total

Review 1.  Mutant TP53 posttranslational modifications: challenges and opportunities.

Authors:  Thuy-Ai Nguyen; Daniel Menendez; Michael A Resnick; Carl W Anderson
Journal:  Hum Mutat       Date:  2014-02-11       Impact factor: 4.878

2.  A role for both Ets and C/EBP transcription factors and mRNA stabilization in the MAPK-dependent increase in p21 (Cip-1/WAF1/mda6) protein levels in primary hepatocytes.

Authors:  J S Park; L Qiao; D Gilfor; M Y Yang; P B Hylemon; C Benz; G Darlington; G Firestone; P B Fisher; P Dent
Journal:  Mol Biol Cell       Date:  2000-09       Impact factor: 4.138

3.  The DNA binding and accumulation of p53 from breast cancer cell lines and the link with serine 15 phosphorylation.

Authors:  Debolina Ray; Keith R Murphy; Susannah Gal
Journal:  Cancer Biol Ther       Date:  2012-08-01       Impact factor: 4.742

4.  Anti-cancer activity of ZnO chips by sustained zinc ion release.

Authors:  Seong-Hee Moon; Won Jin Choi; Sik-Won Choi; Eun Hye Kim; Jiyeon Kim; Jeong-O Lee; Seong Hwan Kim
Journal:  Toxicol Rep       Date:  2016-03-19

Review 5.  Regulators of Oncogenic Mutant TP53 Gain of Function.

Authors:  Satomi Yamamoto; Tomoo Iwakuma
Journal:  Cancers (Basel)       Date:  2018-12-20       Impact factor: 6.639

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.